{
  "LinkTitle": "D-2022-1596",
  "Status": "Initial",
  "InitialDMPReviewStatus": "Reviewed",
  "Funder": "IOF",
  "ProjectTitle": "Validation of TRPM3 as a target for neuropathic pain",
  "InitialFeedbackHistory": "16/05/2022 2. Please briefly describe the methods that you are using to generate the datasets and origin of the samples/models. Please also include physical data: samples, animal models etc. [REDACTED] don't have to mention documentation and manuscripts here. 3. [REDACTED] Please include the ECD approval number and UZL ethics and biobank approval numbers for the use of human tissues. [REDACTED] 5 you mention the 2008 law but make sure you study is compliant with the 2018 biobank law. [REDACTED] more information: www.uzleuven.be/en/uz-kuleuven-biobank. [REDACTED] also mention private data under 5 while you write that you are not using personal data under 3, please list your privacy approval number if you collect personal data. 4,5,6 [REDACTED] [REDACTED] [REDACTED] [REDACTED] give a lot of information here for some of which I don't see a direct link with the data that you are mentioning in 2. [REDACTED] all of this information relevant for this specific project? [REDACTED] would be helpful to indicate per dataset which documentation and storage you are using. 7. [REDACTED] sharing: [REDACTED] you considered any specific repositories to preserve and share your data? [REDACTED] can also use KU [REDACTED] RDR (https://www.kuleuven.be/rdm/en/rdr) or domain specific repositories; F1000 research also gives a good list of recommendations (https://f1000research.com/for-authors/data-guidelines). Please revise your DMP and only mention what is relevant for your specific study and upload your updated DMP as intermediate DMP. [REDACTED] you work with personal data, human participants or human bodily material ensure you have ethics and privacy approval before starting and list the reference numbers in your DMP.",
  "label": "good with suggestions"
}